Search results
... and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis - Gilead ...
Benzinga· 1 hour agoGilead Sciences, Inc. GILD, following the recent acquisition of CymaBay Therapeutics, Inc., today announced two-year interim results from the ongoing ASSURE ...
The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR
Zacks via Yahoo Finance· 18 hours agoStocks recently featured in the blog include: NextEra Energy, Inc. NEE, BP p.l.c. BP, Gilead ...
Paulson Wealth Management Inc. Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoPaulson Wealth Management Inc. grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.3% in the 4th quarter, according to its most ...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 1 day agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
... Is Arcus Biosciences Stock Trading Higher Today? - Arcus Biosciences (NYSE:RCUS), Gilead ...
Benzinga· 2 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free ...
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention...
Benzinga· 9 hours agoThe mid-stage studies will assess the safety, acceptability, and pharmacokinetics (how a drug moves...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 5 days agoGilead Sciences has reported that its Phase III TROPiCS-04 clinical trial of Trodelvy in patients...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via AOL· 5 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
...Most Common Type Of Bladder Cancer Why Is Gilead Sciences Stock Trading Lower On Friday? - Gilead...
Benzinga· 5 days agoOn Thursday, Gilead Sciences Inc GILD announced topline results from the confirmatory Phase 3...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...